PlainRecalls
FDA Drug Moderate Class II Terminated

Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15

Reported: August 9, 2017 Initiated: June 19, 2017 #D-1036-2017

Product Description

Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15

Reason for Recall

Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Details

Recalling Firm
Apace KY LLC
Units Affected
N/A
Distribution
KY
Location
Fountain Run, KY

Frequently Asked Questions

What product was recalled?
Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15. Recalled by Apace KY LLC. Units affected: N/A.
Why was this product recalled?
Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg
Which agency issued this recall?
This recall was issued by the FDA Drug on August 9, 2017. Severity: Moderate. Recall number: D-1036-2017.